Navigation Links
Vaccine Could Cut Bouts With Stomach Flu
Date:2/12/2008

Controlling quickly mutating noroviruses might mean yearly changes in formula

TUESDAY, Feb. 12 (HealthDay News) -- It may be possible to develop a vaccine to control noroviruses -- a common cause of stomach flu -- but it's likely a such a vaccine would have to be changed every year because the viruses evolve quickly to avoid attacks by the immune system, new research suggests.

Noroviruses infect cells after attaching to histo-blood group antigens (HBGA), molecules located on the surface of cells. HBGAs are a family of complex sugar molecules that exist in great variety among humans, according to background information in the study in the journal PLoS Medicine.

Ralph Baric, of the University of North Carolina at Chapel Hill, and his colleagues found this large variety of HBGAs contributes to recurrence of norovirus outbreaks, even among people who have previously been exposed to the virus and have developed antibodies against it.

The researchers analyzed noroviruses that caused several outbreaks and found that the viruses evolved to avoid attack by immune system antibodies.

Over time, some of the norovirus strains developed a shape that enabled them to bind other forms of HBGA. These viruses were then resistant to previously existing antibodies and able to infect cells carrying that particular form of HBGA. These viruses could then cause a new outbreak, with the cycle repeating itself, the researchers said.

Noroviruses, which can cause nausea, vomiting and diarrhea, are highly contagious. Most people recover within a few days, but the viruses can cause severe problems in very young and in old people. There is no specific treatment for norovirus infection.

More information

The U.S. Centers for Disease Control and Prevention has more about noroviruses.



-- Robert Preidt



SOURCE: PLoS Medicine, news release, Feb. 11, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Iomai Study Shows Self-Applied Travelers Diarrhea Vaccine Patch Comparable to Clinician-Applied Vaccine Patch
2. Meningitis vaccine study gets £200,000 boost
3. Tattooing Best Way to Deliver DNA Vaccines
4. Novel molecules developed at UB can boost vaccine potency
5. USDA Agrees to Grant Conditional License to Bioniche for its E. coli O157:H7 Cattle Vaccine
6. Another Study Finds No Link Between MMR Vaccine and Autism
7. New hospital standards needed for pediatric flu vaccines
8. Experimental Vaccine Halts Prostate Cancer in Mice
9. Novel vaccine concept developed by scientists at the Wistar Institute
10. Mercury in Childhood Vaccines Excreted Quickly
11. Childhood Vaccines Save Lives, March Of Dimes Says
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Vaccine Could Cut Bouts With Stomach Flu
(Date:4/28/2016)... ... April 28, 2016 , ... Sanford ... this week. A group of researchers and leaders from Sanford Health were selected ... Medicine and Its Cultural Impact ” and receive the 2016 Pontifical Key Innovation ...
(Date:4/28/2016)... ... April 28, 2016 , ... Head Over Heels Athletic Arts’ gymnast, ... The competition will be held at the University of Montana on April 28-May 1. ... the Mississippi River. , In order to qualify, Varize needed to place top seven ...
(Date:4/28/2016)... Angeles, CA (PRWEB) , ... April 28, 2016 , ... ... on its website, cosmetictown.com . The forum section was recently revamped and upgraded ... the latest surgical techniques in use across the country. , According to the senior ...
(Date:4/28/2016)... ... April 28, 2016 , ... In 2011, TIME magazine named ... emerging field of biomechatronics, technology that marries human physiology with electromechanics. He continues that ... is also the Founder of BionX , a leader in the field of ...
(Date:4/28/2016)... ... April 28, 2016 , ... One way to ignore ... This is unfortunately true. But we toss the baby out with the bathwater when ... provides tips for identifying higher-quality studies and otherwise making better use of education policy ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... -- TapImmune,Inc. (TPIV), a clinical-stage immune-oncology ... immunotherapeutics and vaccines for the treatment of cancer & metastatic ... Annual Growth Capital Expo to be held on May ... Palace in Las Vegas, Nevada.  The Company presentation will ... by Dr. John N. Bonfiglio a TapImmune ...
(Date:4/27/2016)... Inc. (Nasdaq: HOLX ) announced today ... quarter ended March 26, 2016.  GAAP diluted earnings ... non-GAAP diluted EPS of $0.47 increased 14.6%.  Revenue ... basis, and 6.3% on a constant currency basis.  ... highlighted by 14.6% growth in non-GAAP EPS," said ...
(Date:4/27/2016)... 2016   ... sur le trimestre, soutenu par une croissance de ... Croissance de +16% des ventes aux hôpitaux et ... Technologies (Euronext : MKEA, FR0010609263 ; OTCQX : MKEAY), inventeur de ... son chiffre d,affaires pour le premier trimestre clos ...
Breaking Medicine Technology: